Press Releases

Nov 14, 2022

Lanier Biotherapeutics Announces Issuance of U.S. Patent for IL-25 Binding Molecules

Read More
May 13, 2022

Lanier Biotherapeutics to Present Seminal LNR125 Publication at American Thoracic Society Meeting

Read More
Oct 6, 2021

Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics

Read More

In The News

July 9, 2021

Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors

Read More